VORANIGO (R) was approved by Health Canada in August 2024 for the treatment of Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation in adults and pediatric patients aged ...
The board took in some good news on student performance and student health as the district continues to work toward a $15 ...
A standout Oakland high school student-athlete is being celebrated for not only his academic achievements, but his leadership by example and his contributions on and off the basketball court.
Data support emergence of differentiating clinical benefit with a favorable safety and tolerability profile for patients with ...
After she played the last game of her career on the Nutter Center court Wednesday night, Lauren Scott took a seat just outside the dressing room and looked back over her four years at Wright State.
The Rotary Club of Penticton Sunrise is delighted to name Samantha Betz, an immensely gifted, laser-focused, industrious and ...
King's College London today announced the launch of VISI-ON-BRAIN (Cutting-edge Human In Vitro and In Silico Biomedical Tools on Brain Disorders), a ...
Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...
Ionis Pharmaceuticals, Inc. today announced new data to be presented for DAWNZERAtm (donidalorsen), the first and only RNA-targeted medicine for hereditary angioedema (HAE), including new analyses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results